SL BIO Ltd. (SLBT) commenced trading on the Nasdaq Global Market beginning on June 15, 2026, following a business combination with Horizon Space Acquisition II Corp. (Nasdaq: HSPT), a special purpose acquisition company.
The completion of this business combination carries an implied equity valuation of SL Bio of approximately $5.568 billion.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
by Prabha Kurup
For comments and feedback: contact editorial@rttnews.com